Back to dashboard
Medicare AdvantagePrior AuthHigh impact

Medical policy updates

Blue Cross Blue Shield of Rhode Island·Endocrinology, Gastroenterology, Oncology +5 more·Physician / Facility
Effective date
Feb 1, 2026
We identified it
Jun 19, 2026
Days to comply

Summary

Multiple policy updates are rolling out between February-April 2026, including InterQual criteria changes for molecular diagnostics and procedures, fertility coverage modifications, removal of prior authorization for several genetic testing and continuous glucose monitoring codes, and updated diagnosis code lists for various services.

Action Required

Action needed
By February 1, 2026: Update InterQual authorization tool access for molecular diagnostics criteria including Alzheimer's Disease and DPYD Testing. By March 1, 2026: Remove prior authorization requirements for CPT 0446T, 0447T, 0448T (continuous glucose monitoring) and update system for renal RFA/cryoablation procedures. By April 1, 2026: Major updates required - remove prior authorization for multiple genetic testing codes (81315, 81316, 81345 with specific diagnoses), update fertility coverage criteria removing EmbryoGlue coverage, add covered diagnosis codes for acute hepatitis panel (80074), and implement new medical necessity criteria for back pain procedures (64628/64629) and sleep apnea treatments (64568). Billing team must update system edits, authorization requirements, and covered diagnosis lists across all affected codes.

Affected Billing Codes

80074
81190
81315
81316
81345
81220
81270
81279
64628
64629
64568
83700
83701
83704
S9355
R10.20
R10.21
R10.22
R10.23
R10.24
R10.2
C71.0
C71.1
C71.2
C71.3
C71.4
C71.5
C71.6
C71.7
C71.8
C71.9
E84.8
E88.10
E88.11
E88.12
E88.13
E88.14
E88.19
E78.010
E78.011
E78.019
E11.A
G35
G35.A
G35.B
G35.C
G35.D